Pain Injection Versus Epidural Anesthesia for Hip Surgery in Pediatric Patients With Cerebral Palsy

PHASE4RecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

December 30, 2026

Study Completion Date

June 30, 2027

Conditions
Cerebral PalsyHip DysplasiaPain, Postoperative
Interventions
DRUG

Ropivacaine injection

The local anesthetic group will be injected with ropivacaine 2mg/mL (3mg/kg), epinephrine 1mg/mL (0.5mg), and ketorolac 30mg/mL (0.5mg/kg). The maximum dose of ropivacaine regardless of patient weight will be 200mg. This is based on recommended maximum dose protocols from our anesthesia colleagues. If bilateral hips are involved, the total amount will be split evenly between the two sides.

DRUG

Bupivacaine, lidocaine, ropivacaine

The lumbar epidural group will receive a combination of either/or bupivacaine, lidocaine, and ropivacaine, which will be monitored by the anesthesia team.

Trial Locations (4)

60611

NOT_YET_RECRUITING

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago

90007

RECRUITING

Orthopaedic Institute for Children, Los Angeles

90095

RECRUITING

Ronald Reagan UCLA Medical Center, Los Angeles

90404

RECRUITING

UCLA Medical Center, Santa Monica, Santa Monica

All Listed Sponsors
collaborator

Northwestern University

OTHER

lead

University of California, Los Angeles

OTHER